Jonathan M. Cohen
Chief Executive Officer, Director, 10% Owner · 20/20 Biolabs, Inc.
Individual
- 2026
- Mar 4, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Jonathan M. Cohen's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- TPG GP A, LLC - $742.97M in LFST purchases and sales in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
- Keith A. Meister - $591.13M in ILMN purchases and sales in the last 12 months
- Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
- Mozart Aggregator II LP - $579.20M in MDLN purchases and sales in the last 12 months
- TC Group VII S1, L.L.C. - $554.95M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jonathan M. Cohen?
Jonathan M. Cohen is a corporate insider, tracked as Chief Executive Officer, Director, 10% Owner of 20/20 Biolabs, Inc. (AIDX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jonathan M. Cohen last file a Form 4?
The only primary Form 4 on record is dated 4 March 2026.